Who
Kevin Schuyler
Director
Company insider
Files Form 4 as: Director and 10% owner, Adial Pharmaceuticals; Director, Twin Vee PowerCats Co; Director, Forza X1.
In numbers
- Trades disclosed
- 69
- Buys
- 9
- Sells
- 0
- Bought
- $63K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 31 Jul 2018
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —9,185 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —9,185 at $0.00 | filing |
| 19 Mar 2026filed 19 Mar 2026 | VEEE Twin Vee PowerCats CoLeisure Products & Vehicles | SEC FORM 4 Bought | $10K25,000 at $0.4066 | filing |
| 19 Mar 2026filed 19 Mar 2026 | VEEE Twin Vee PowerCats CoLeisure Products & Vehicles | SEC FORM 4 Bought | $10K25,000 at $0.41 | filing |
| 29 May 2025filed 2 Jun 2025 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | VEEE Twin Vee PowerCats Cooption or derivative · Leisure Products & Vehicles | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 26 Nov 2024filed 26 Nov 2024 | VEEE Twin Vee PowerCats Cooption or derivative · Leisure Products & Vehicles | SEC FORM 4 Code A | —3,364 | filing |
| 26 Nov 2024filed 26 Nov 2024 | VEEE Twin Vee PowerCats CoLeisure Products & Vehicles | SEC FORM 4 Code A | —61,166 | filing |
| 26 Nov 2024filed 26 Nov 2024 | Forza X1option or derivative | SEC FORM 4 Code D | —5,500 | filing |
| 26 Nov 2024filed 26 Nov 2024 | Forza X1 | SEC FORM 4 Code D | —100,000 | filing |
| 17 Sep 2024filed 18 Sep 2024 | Forza X1 | SEC FORM 4 Bought | $27K90,668 at $0.30 | filing |
| 16 Aug 2024filed 20 Aug 2024 | VEEE Twin Vee PowerCats Cooption or derivative · Leisure Products & Vehicles | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 25 Mar 2024filed 27 Mar 2024 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 29 Sep 2023filed 3 Oct 2023 | ADIL Adial PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $1,918700 at $2.74 | filing |
| 23 May 2023filed 25 May 2023 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Dec 2022filed 22 Dec 2022 | VEEE Twin Vee PowerCats CoLeisure Products & Vehicles | SEC FORM 4 Bought | $1,062600 at $1.77 | filing |
| 22 Dec 2022filed 22 Dec 2022 | Forza X1 | SEC FORM 4 Bought | $5,7005,000 at $1.14 | filing |
| 21 Dec 2022filed 22 Dec 2022 | VEEE Twin Vee PowerCats CoLeisure Products & Vehicles | SEC FORM 4 Bought | $1,366763 at $1.79 | filing |
| 20 Dec 2022filed 21 Dec 2022 | Forza X1 | SEC FORM 4 Bought | $5,1984,332 at $1.20 | filing |
| 11 Aug 2022filed 12 Aug 2022 | Forza X1option or derivative | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.